Green Technologies in The Pharmaceutical Industry: Modern Approaches to Ecologically Safe Drug Manufacturing

Authors

  • Malika Komiljonovna Usmonova Scientific Supervisor, Acting Associate Professor (PhD), Department of Pharmacy and Chemistry, Alfraganus University, Uzbekistan
  • Kocherova Umida 4th-year student, Faculty of Dentistry and Pharmacy, Pharmacy Program, Alfraganus University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.37547/ijasr-06-08-15

Keywords:

Green pharmacy, green chemistry, pharmaceutical manufacturing

Abstract

The pharmaceutical industry provides essential medicines and contributes substantially to public health, yet its manufacturing processes may consume significant amounts of energy, water, solvents and raw materials and can generate complex waste streams. Green technologies offer a pathway to reduce these environmental burdens without compromising pharmaceutical quality, safety or efficacy. This article reviews contemporary approaches to greener pharmaceutical manufacturing, including green chemistry, solvent selection, process intensification, continuous manufacturing, renewable energy, water conservation, waste minimization, sustainable packaging and responsible management of unused medicines. Particular attention is given to the application of the principles of prevention, safer synthesis and resource efficiency throughout the pharmaceutical product life cycle. The article also considers the role of pharmacists and pharmaceutical organizations in promoting environmentally responsible practices. Implementation of green technologies requires cooperation among scientists, manufacturers, regulators and healthcare professionals, as well as appropriate economic and educational incentives. Integrating environmental considerations into pharmaceutical development can contribute to cleaner production, more efficient resource use and long-term sustainability of the healthcare system.

References

1. Anastas, P. T., & Warner, J. C. (1998). Green Chemistry: Theory and Practice. Oxford University Press.

2. Sheldon, R. A. (2017). The E factor: fifteen years on. Green Chemistry, 19, 18–43.

3. Jiménez-González, C., Ponder, C. S., Broxterman, Q. B., & Manley, J. B. (2004). Using the right green yardstick: Why process mass intensity is used in the pharmaceutical industry. Organic Process Research & Development, 8(6), 939–945.

4. Constable, D. J. C., Curzons, A. D., Cunningham, V. L., et al. (2002). Green chemistry and sustainability in the pharmaceutical industry. Green Chemistry, 4, 521–527.

5. International Council for Harmonisation (ICH). (2023). ICH Q13: Continuous Manufacturing of Drug Substances and Drug Products.

6. U.S. Environmental Protection Agency (EPA). (2024). Green Chemistry and Safer Choice: Principles and approaches for pollution prevention.

7. World Health Organization (WHO). (2019). WHO good manufacturing practices for pharmaceutical products: main principles.

8. European Medicines Agency (EMA). (2024). Environmental risk assessment of medicinal products for human use: scientific guidance.

Downloads

Published

2026-08-26

How to Cite

Malika Komiljonovna Usmonova, & Kocherova Umida. (2026). Green Technologies in The Pharmaceutical Industry: Modern Approaches to Ecologically Safe Drug Manufacturing. International Journal of Advance Scientific Research, 6(08), 236-241. https://doi.org/10.37547/ijasr-06-08-15

Similar Articles

21-30 of 66

You may also start an advanced similarity search for this article.